Barclays has maintained an “Overweight” recommendation for Bruker Corporation – Preferred Stock (NasdaqGS:BRKRP) as of December 15, 2025. The average one-year price target for the stock is $365.60, indicating a potential upside of 4.68% from its recent closing price of $349.25. The price targets range from a low of $280.10 to a high of $606.66.
Additionally, projected annual non-GAAP earnings per share (EPS) is expected to be 2.01. Notable shareholders include Aequim Alternative Investments with 300k shares, D. E. Shaw with 205k shares, and Franklin Resources with 200k shares.
